250 related articles for article (PubMed ID: 31471642)
1. [Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options].
Uhlig A
Urologe A; 2019 Oct; 58(10):1208-1211. PubMed ID: 31471642
[No Abstract] [Full Text] [Related]
2. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
3. Medical treatment options in patients with metastatic renal cell carcinoma.
Haferkamp A; Hohenfellner M
Nephrol Dial Transplant; 2007 Apr; 22(4):996-9. PubMed ID: 17210591
[No Abstract] [Full Text] [Related]
4. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M; Gore M; Eisen T
J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
[TBL] [Abstract][Full Text] [Related]
5. Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Di Nunno V; Gatto L; Fragomeno B; Cubelli M; Nobili E; Romano I; Santoni M; Pisconti S; Montironi R; Massari F
Future Oncol; 2018 Dec; 14(29):2997-2999. PubMed ID: 30411632
[No Abstract] [Full Text] [Related]
6. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK; Vogelzang N
Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
[No Abstract] [Full Text] [Related]
7. Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
Rini BI; Zimmerman TM; Gajewski TF; Stadler WM; Vogelzang NJ
J Urol; 2001 Apr; 165(4):1208-9. PubMed ID: 11257677
[No Abstract] [Full Text] [Related]
8. Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ.
Shinohara N; Abe T; Sazawa A; Maruyama S; Shindo J; Sato S; Suzuki S; Nonomura K
Jpn J Clin Oncol; 2012 Feb; 42(2):113-9. PubMed ID: 22131341
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.
van Herpen CM; De Mulder PH
Crit Rev Oncol Hematol; 2002 Mar; 41(3):327-34. PubMed ID: 11880208
[TBL] [Abstract][Full Text] [Related]
10. First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options.
Loo V; Salgia M; Bergerot P; Philip EJ; Pal SK
Target Oncol; 2019 Dec; 14(6):639-645. PubMed ID: 31595385
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
Guida M; Colucci G
Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810
[TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy of metastatic renal cell carcinoma.
Bukowski RM
Cancer Invest; 1999; 17(6):460-1. PubMed ID: 10434957
[No Abstract] [Full Text] [Related]
13. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
Pandha H
Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
[No Abstract] [Full Text] [Related]
14. Combination systemic therapy for advanced renal cell carcinoma.
Miller RE; Larkin JM
Oncologist; 2009 Dec; 14(12):1218-24. PubMed ID: 19939892
[TBL] [Abstract][Full Text] [Related]
15. Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma.
Schrader AJ; Heidenreich A; Hegele A; Olbert P; Ohlmann CH; Varga Z; von Knobloch R; Hofmann R
Anticancer Drugs; 2005 Jun; 16(5):581-5. PubMed ID: 15846124
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapeutic treatment for metastatic renal carcinoma].
Hidalgo Pardo F; Gutiérrez Sanz-Gadea C; Rebassa Llull MJ; García Bueno JM; Mus Malleu A; Losada González GP; Ozonas Moragues M
Actas Urol Esp; 1998 Jan; 22(1):29-33. PubMed ID: 9542189
[TBL] [Abstract][Full Text] [Related]
18. [Medical therapies for locally advanced/metastatic kidney cancer].
Afrit M; Yahyaoui Y; Bouzouita A; Hantous S; Labidi S; Chebil M; Ben Miled K; Escudier B; Boussen H
Presse Med; 2015 Feb; 44(2):135-43. PubMed ID: 25535168
[TBL] [Abstract][Full Text] [Related]
19. Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy.
Kim SH; Park WS; Kim SH; Joung JY; Seo HK; Lee KH; Chung J
Cancer Res Treat; 2016 Jul; 48(3):1092-101. PubMed ID: 26875203
[TBL] [Abstract][Full Text] [Related]
20. Clinical decision-making for immunotherapy in metastatic renal cell carcinoma.
Schmidinger M
Curr Opin Urol; 2018 Jan; 28(1):29-34. PubMed ID: 29045250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
